Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Walles

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Pharmacological Research|July 20, 2023
The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug developmentMarit Keuper-Navis, Markus Walles, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 24, 2014
Phase II metabolism in human skin: skin explants show full coverage for glucuronidation, sulfation, N-acetylation, catechol methylation, and glutathione conjugationNenad Manevski, Piet Swart, Kamal Kumar Balavenkatraman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White PaperEugenia Kraynov, Amrita V Kamath, Markus Walles, et al.
Clinical Pharmacology and Therapeutics|October 17, 2021
Risk-Based Pharmacokinetic and Drug-Drug Interaction Characterization of Antibody-Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development PerspectiveChunze Li, Rajeev Menon, Markus Walles, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Pharmacological Research|July 20, 2023
The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug developmentMarit Keuper-Navis, Markus Walles, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 24, 2014
Phase II metabolism in human skin: skin explants show full coverage for glucuronidation, sulfation, N-acetylation, catechol methylation, and glutathione conjugationNenad Manevski, Piet Swart, Kamal Kumar Balavenkatraman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White PaperEugenia Kraynov, Amrita V Kamath, Markus Walles, et al.
Clinical Pharmacology and Therapeutics|October 17, 2021
Risk-Based Pharmacokinetic and Drug-Drug Interaction Characterization of Antibody-Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development PerspectiveChunze Li, Rajeev Menon, Markus Walles, et al.
Pageof 5